RGIN OTC
Regenicin, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -66.7%
1Y: +0.0%
3Y: -97.1%
5Y: -99.2%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.7501
Volume99,100
Avg Volume92,503
Beta-2.27
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORandall E. McCoy
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2009-11-16
Websiteregenicin.com
10 High Court
Little Falls, NJ 07424
US
Little Falls, NJ 07424
US
973 557 8914
About Regenicin, Inc.
Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Recent Insider Trades
No insider trades found